Choriocapillaris Flow Deficits and Treatment-Naïve Macular Neovascularization Secondary to Age-Related Macular Degeneration.
Aged
Choroid
/ blood supply
Cross-Sectional Studies
Female
Fluorescein Angiography
/ methods
Follow-Up Studies
Fundus Oculi
Humans
Macular Degeneration
/ complications
Male
Regional Blood Flow
/ physiology
Retinal Neovascularization
/ diagnosis
Retinal Vessels
/ diagnostic imaging
Retrospective Studies
Tomography, Optical Coherence
/ methods
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
1
4
2021
Statut:
ppublish
Résumé
To evaluate choriocapillaris (CC) flow deficits (FD) in eyes with treatment-naïve macular neovascularization (MNV) and to compare CC FD around exudative versus nonexudative MNV. Treatment-naïve eyes with a diagnosis of either exudative or nonexudative AMD and type 1 MNV were included. Normal control eyes were age-matched to each AMD eye one to one. En face optical coherence tomography angiograms were analyzed for percentage of CC FD (FD%) in two concentric 500 µm rings, ring 1 and ring 2, surrounding the dark halo around MNV. The mean CC FD% in ring 1 and ring 2 was evaluated for each eye. A secondary analysis was similarly carried out to investigate the differences in CC FD% in exudative versus nonexudative treatment-naïve MNV. Twenty-three eyes with treatment-naïve MNV were age matched with 23 normal controls. The mean CC FD% was significantly greater in both rings in the MNV versus the normal control group (P < 0.05) and was significantly greater in the inner ring, closer to the lesion, than the outer ring. The mean FD% was also greater in both rings in the exudative versus the nonexudative MNV group, but this difference did not reach statistical significance. The CC FD% was greater in the area surrounding MNV versus age-matched normal controls and in the ring closer to the MNV lesion. Further, CC FD was greater in eyes with exudative versus nonexudative MNV in both rings surrounding the associated dark halo, although this difference was not statistically significant.
Identifiants
pubmed: 32902576
pii: 2770771
doi: 10.1167/iovs.61.11.11
pmc: PMC7488611
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11Références
Retina. 2020 Mar;40(3):428-445
pubmed: 31415449
PLoS One. 2020 Mar 20;15(3):e0230260
pubmed: 32196538
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5548-5555
pubmed: 29075766
Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):496-505
pubmed: 25423628
Hypoxia (Auckl). 2017 Apr 11;5:21-32
pubmed: 28443291
Am J Ophthalmol. 2018 Dec;196:34-43
pubmed: 30118688
J Ophthalmol. 2018 Jan 30;2018:8125267
pubmed: 29651346
Ophthalmology. 2017 Jul;124(7):944-952
pubmed: 28318637
Br J Ophthalmol. 2019 Jul;103(7):911-917
pubmed: 30131381
Am J Ophthalmol. 2019 Dec;208:397-405
pubmed: 31493401
Ophthalmol Retina. 2018 Sep;2(9):922-930
pubmed: 31047227
Ophthalmology. 2008 Jan;115(1):116-26
pubmed: 17675159
PLoS One. 2018 Nov 15;13(11):e0207638
pubmed: 30440050
Am J Ophthalmol. 2017 Oct;182:45-55
pubmed: 28734811
Transl Vis Sci Technol. 2018 Oct 1;7(5):19
pubmed: 30280004
Ophthalmol Retina. 2019 Aug;3(8):629-636
pubmed: 31068262
Invest Ophthalmol Vis Sci. 2013 Oct 21;54(10):6886-92
pubmed: 24084095
Acta Ophthalmol. 2017 Jun;95(4):428-430
pubmed: 27659278
Retina. 2016 Dec;36 Suppl 1:S2-S11
pubmed: 28005659
Trans Am Ophthalmol Soc. 1977;75:180-254
pubmed: 613523
Ophthalmologica. 1985;190(1):30-9
pubmed: 2578633
Ophthalmic Surg Lasers Imaging Retina. 2018 Dec 1;49(12):918-924
pubmed: 30566698
Am J Ophthalmol. 2020 Apr 28;:
pubmed: 32360341
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):203-211
pubmed: 29340648
Am J Ophthalmol. 2019 Sep;205:132-139
pubmed: 31078531
Biomed Opt Express. 2012 Jun 1;3(6):1182-99
pubmed: 22741067
Br J Ophthalmol. 1973 Dec;57(12):951-65
pubmed: 4788954
Retina. 2020 Jul;40(7):1224-1233
pubmed: 31259809
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4982-91
pubmed: 19357355
Br J Ophthalmol. 2020 Aug;104(8):1057-1063
pubmed: 31662311
Retina. 2018 Feb;38(2):220-230
pubmed: 28582276
Am J Ophthalmol. 2019 Sep;205:54-65
pubmed: 30885708
Retina. 2015 Nov;35(11):2219-28
pubmed: 26398697
Biomed Opt Express. 2014 Jul 11;5(8):2591-613
pubmed: 25136488
Prog Retin Eye Res. 2018 Nov;67:30-55
pubmed: 30059755
Mol Aspects Med. 2012 Aug;33(4):295-317
pubmed: 22542780
Am J Ophthalmol. 2016 Sep;169:189-198
pubmed: 27394033
Am J Ophthalmol. 2019 Dec;208:111-123
pubmed: 31323202
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
Ophthalmology. 2014 Jul;121(7):1435-44
pubmed: 24679442
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Am J Ophthalmol. 2019 Apr;200:110-122
pubmed: 30639367
Br J Ophthalmol. 2019 Sep;103(9):1342-1346
pubmed: 30467129
Neurobiol Aging. 2014 Nov;35(11):2562-2573
pubmed: 24925811
Prog Retin Eye Res. 2017 Sep;60:66-100
pubmed: 28760677
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4792-4798
pubmed: 28973325